Anna Dmitrievna Yanina

Title: Anna Dmitrievna Yanina: Innovator in Allergy Treatment

Introduction

Anna Dmitrievna Yanina is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of medicine, particularly in the treatment of allergic diseases. With a total of 2 patents, her work showcases her dedication to advancing healthcare solutions.

Latest Patents

Yanina's latest patents include a medicated compound for treating allergic diseases. This compound consists of an active principle, specifically (quinuclidyl-3)-diphenylcarbinol hydrochloride, combined with a pharmaceutical filler or solvent for injection solutions. Another notable patent involves a method for achieving antihistaminic, antiserotonin, and antiallergic effects. This method is accomplished by administering a (quinuclidyl-3)-diaryl (heteryl)carbinol, which can be formulated with various physiologically compatible acids.

Career Highlights

Throughout her career, Anna Yanina has focused on developing innovative treatments that address the needs of patients suffering from allergies. Her research has led to breakthroughs that enhance the effectiveness of allergy medications, making her a valuable contributor to the medical community.

Collaborations

Yanina has collaborated with notable colleagues, including Mikhail D Mashkovsky and Mikhail Emmanuilovich Kaminka. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of allergy treatment.

Conclusion

Anna Dmitrievna Yanina's work in developing medicated compounds for allergic diseases highlights her commitment to improving patient care. Her innovative patents and collaborations with esteemed colleagues underscore her impact on the medical field.